Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Goodman

Showing results (781-790 of 1,119) with videos related to

Pageof 112
Sort By:
Heart (British Cardiac Society)|June 17, 2005
Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patternsP Kaul, L K Newby, Y Fu, et al.
The Canadian Journal of Cardiology|March 13, 2023
Race and Ethnicity With Atherosclerotic Cardiovascular Disease Outcomes Within a Universal Health Care System: Insights From the CARTaGENE StudyMarc-André d'Entremont, Dennis Ko, Andrew T Yan, et al.
Journal of the American Heart Association|June 14, 2022
Sex-Specific Differences in Clinical Outcomes After Percutaneous Coronary Intervention: Insights from the TAILOR-PCI TrialMina Madan, J Dawn Abbott, Ryan Lennon, et al.
The American Journal of Cardiology|May 6, 2014
Prognostic implications of prominent R wave in electrocardiographic leads V1 or V2 in patients with acute coronary syndromeWael A Alqarawi, Shaun G Goodman, Raymond T Yan, et al.
International Journal of Cardiology|March 8, 2017
Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational studyShaun G Goodman, Jose C Nicolau, Gema Requena, et al.
Journal of the American College of Cardiology|October 3, 2006
A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromesMarc Cohen, Kenneth W Mahaffey, Karen Pieper, et al.
American Heart Journal|December 24, 2003
Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE)Mark I Furman, Joel M Gore, Fredrick A Anderson, et al.
International Journal of Clinical Practice|March 29, 2012
Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort studyM F B Braga, A Casanova, H Teoh, et al.
The American Journal of Cardiology|November 15, 2011
Relation between previous angiotensin-converting enzyme inhibitor use and in-hospital outcomes in acute coronary syndromesSheldon M Singh, Shaun G Goodman, Raymond T Yan, et al.
Gastroenterology|April 1, 1978
A model of fulminant hepatic failure in the rabbitB L Blitzer, J G Waggoner, E A Jones, et al.
Pageof 112

Showing results (781-790 of 1,119) with videos related to

Sort By:
Pageof 112
Heart (British Cardiac Society)|June 17, 2005
Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patternsP Kaul, L K Newby, Y Fu, et al.
The Canadian Journal of Cardiology|March 13, 2023
Race and Ethnicity With Atherosclerotic Cardiovascular Disease Outcomes Within a Universal Health Care System: Insights From the CARTaGENE StudyMarc-André d'Entremont, Dennis Ko, Andrew T Yan, et al.
Journal of the American Heart Association|June 14, 2022
Sex-Specific Differences in Clinical Outcomes After Percutaneous Coronary Intervention: Insights from the TAILOR-PCI TrialMina Madan, J Dawn Abbott, Ryan Lennon, et al.
The American Journal of Cardiology|May 6, 2014
Prognostic implications of prominent R wave in electrocardiographic leads V1 or V2 in patients with acute coronary syndromeWael A Alqarawi, Shaun G Goodman, Raymond T Yan, et al.
International Journal of Cardiology|March 8, 2017
Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational studyShaun G Goodman, Jose C Nicolau, Gema Requena, et al.
Journal of the American College of Cardiology|October 3, 2006
A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromesMarc Cohen, Kenneth W Mahaffey, Karen Pieper, et al.
American Heart Journal|December 24, 2003
Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE)Mark I Furman, Joel M Gore, Fredrick A Anderson, et al.
International Journal of Clinical Practice|March 29, 2012
Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort studyM F B Braga, A Casanova, H Teoh, et al.
The American Journal of Cardiology|November 15, 2011
Relation between previous angiotensin-converting enzyme inhibitor use and in-hospital outcomes in acute coronary syndromesSheldon M Singh, Shaun G Goodman, Raymond T Yan, et al.
Gastroenterology|April 1, 1978
A model of fulminant hepatic failure in the rabbitB L Blitzer, J G Waggoner, E A Jones, et al.
Pageof 112